Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma
The stock opened higher at ₹429.05, before declining sharply, with sell orders outpacing buys roughly 70-30
open_in_new
open_in_new
Read Full Article on Hindu BusinessLine
Original Article
Published on Hindu BusinessLine
● Neutral
Source: Hindu BusinessLine
open_in_new